0000899243-17-026986.txt : 20171120 0000899243-17-026986.hdr.sgml : 20171120 20171120165518 ACCESSION NUMBER: 0000899243-17-026986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171116 FILED AS OF DATE: 20171120 DATE AS OF CHANGE: 20171120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Braslyn Ltd. CENTRAL INDEX KEY: 0001642355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 171214327 BUSINESS ADDRESS: STREET 1: CAY HOUSE STREET 2: EP TAYLOR DRIVE N7776 CITY: LYFORD CAY, NEW PROVIDENCE STATE: C5 ZIP: 00000 BUSINESS PHONE: 407-909-9970 MAIL ADDRESS: STREET 1: CAY HOUSE STREET 2: EP TAYLOR DRIVE N7776 CITY: LYFORD CAY, NEW PROVIDENCE STATE: C5 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boxer Capital, LLC CENTRAL INDEX KEY: 0001465837 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 171214328 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 320 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 400-3112 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 320 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-16 0 0001576263 Mirati Therapeutics, Inc. MRTX 0001465837 Boxer Capital, LLC 11682 EL CAMINO REAL, SUITE 320 SAN DIEGO CA 92130 0 0 1 0 0001642355 Braslyn Ltd. C/O CAY HOUSE P.O. BOX N-7776 E.P. TAYLOR DRIVE LYFORD CAY NEW PROVIDENCE C5 BAHAMAS 0 0 1 0 Common Stock 2017-11-16 4 P 0 144736 13.00 A 1372510 D Common Stock 2017-11-16 4 P 0 255264 13.00 A 3135966 D Warrant (right to purchase) 0.001 2017-11-16 4 P 0 801448 12.999 A 2017-11-16 Common Stock 801448 801448 D Warrant (right to purchase) 0.001 2017-11-16 4 P 0 1413475 12.999 A 2017-11-16 Common Stock 1413475 1413475 D These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. ("Braslyn"), (ii) Boxer Capital, (iii) Boxer Asset Management Inc. ("Boxer Management"), (v) MVA Investors, LLC ("MVA Investors"), (vi) Joseph C. Lewis, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the "Boxer Group), and indirectly by Boxer Management and Messrs. Lewis, Fuglesang, Reisman, Lieberburg, Dissanayake, and Davis, by virtue of their ownership in Boxer Capital. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interes These securities are owned directly by Braslyn, which may be deemed to be a member of the Boxer Group. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn. The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock. Boxer Capital, LLC, By: /s/ Aaron Davis 2017-11-20 Braslyn Ltd., By: /s/ Jason Callender 2017-11-20